Clinical trials: Renal Transplant Candidate for Left Kidney
Latent Tuberculosis, End Stage Renal Disease
One-month Latent Tuberculosis Treatment for Renal Transplant Candidates
This is a prospective, single-center, single-arm, open-label study investigating the safety, compliance and pharmacokinetics of 1-month treatment of Isoniazid, Rifapentine and Vitamin B6 in renal transplant candidates.
- Conditions
- Latent Tuberculosis, End Stage Renal Disease, Renal Transplant Candidate for Right Kidney, Renal Transplant Candidate for Left Kidney
- Trial name
- NCT05411744
- Testing
- 1 month Rifapentine, Isoniazid and Vitamin B6
- Where
- United States
- Volunteers
- 25 people
- Sponsor
- Rutgers, The State University of New Jersey
Renal Transplant Candidate for Right Kidney, Renal Transplant Candidate for Left Kidney
ACToR-study : Angiographic CT of Renal Transplantation Candidate - Study
This study hypothesizes that renal transplantation candidates are diagnosed with significant Coronary Artery Disease (CAD) equal with non-invasive modalities as with invasive modalities.
- Trial name
- ACToR (NCT01344434)
- Where
- Denmark
- Volunteers
- 167 people
- Sponsor
- University of Aarhus
Renal Transplant Candidate for Right Kidney, Renal Transplant Candidate for Left Kidney
Evaluation of Regret in Kidney Transplantation
Decisional regret is a negative feeling, involving distress or remorse following a decision. This has been studied in several areas such as psychology, economy or marketing.
- Trial name
- DONOR (NCT05282381)
- Testing
- DRS : Decision Regret Scale
- Where
- France
- Volunteers
- 250 people
- Sponsor
- University Hospital, Lille